|
US6777432B1
|
|
Pharmaceutical uses and synthesis of nicotinamides
|
|
EP1967525A2
|
|
A method for regulating immune function in primates using the foxp3 protein
|
|
WO0166766A2
|
|
A matrix metalloproteinase (mmp-25) expressed in skin cell
|
|
CA2306443A1
|
|
Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
|
|
EP1914304A1
|
|
Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
|
|
WO9813527A2
|
|
Compositions and methods for enhancing hybridization specificity
|
|
CA2235671A1
|
|
Methods for preparing solid supports for hybridization and reducing non-specific background
|
|
CA2226255A1
|
|
Chromosome 1 gene and gene products related to alzheimer's disease
|
|
US5512431A
|
|
Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing
|
